Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Marynissen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 19, 2018
Early collapse causing stenosis in a resorbable magnesium scaffoldThomas Marynissen, Keir McCutcheon, Johan Bennett
Acta Cardiologica|September 25, 2012
Ictal asystole: case report with review of literatureThomas Marynissen, Nelly Govers, Tom Vydt
Acta Cardiologica|February 9, 2019
Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffoldKeir McCutcheon, Johan Bennett, Thomas Marynissen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 8, 2013
Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart diseaseThomas Marynissen, Vincent Floré, Hein Heidbuchel, et al.
International Journal of Clinical Pharmacy|May 9, 2014
Frequency of use of QT-interval prolonging drugs in psychiatry in BelgiumEline Vandael, Thomas Marynissen, Johan Reyntens, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 27, 2014
Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experienceSebastiaan Deckx, Thomas Marynissen, Filip Rega, et al.
Acta Cardiologica|February 3, 2015
How to choose between a pacemaker or defibrillator for resynchronization therapy?Carl Gillebert, Thomas Marynissen, Roel Janssen, et al.
Acta Cardiologica|March 22, 2018
Major adverse cardiovascular events while awaiting staged non-culprit percutaneous coronary intervention after ST-segment elevation myocardial infarctionKeir McCutcheon, Andreas S Triantafyllis, Thomas Marynissen, et al.
Pacing and Clinical Electrophysiology : PACE|May 21, 2016
Changes in Implantation Patterns and Therapy Rates of Implantable Cardioverter Defibrillators over Time in Ischemic and Dilated Cardiomyopathy PatientsBert Vandenberk, Christophe Garweg, Gabor Voros, et al.
European Journal of Gastroenterology & Hepatology|May 24, 2012
Transcatheter arterial embolization for iatrogenic hemobilia is a safe and effective procedure: case series and review of the literatureThomas Marynissen, Geert Maleux, Sam Heye, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 19, 2018
Early collapse causing stenosis in a resorbable magnesium scaffoldThomas Marynissen, Keir McCutcheon, Johan Bennett
Acta Cardiologica|September 25, 2012
Ictal asystole: case report with review of literatureThomas Marynissen, Nelly Govers, Tom Vydt
Acta Cardiologica|February 9, 2019
Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffoldKeir McCutcheon, Johan Bennett, Thomas Marynissen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 8, 2013
Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart diseaseThomas Marynissen, Vincent Floré, Hein Heidbuchel, et al.
International Journal of Clinical Pharmacy|May 9, 2014
Frequency of use of QT-interval prolonging drugs in psychiatry in BelgiumEline Vandael, Thomas Marynissen, Johan Reyntens, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 27, 2014
Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experienceSebastiaan Deckx, Thomas Marynissen, Filip Rega, et al.
Acta Cardiologica|February 3, 2015
How to choose between a pacemaker or defibrillator for resynchronization therapy?Carl Gillebert, Thomas Marynissen, Roel Janssen, et al.
Acta Cardiologica|March 22, 2018
Major adverse cardiovascular events while awaiting staged non-culprit percutaneous coronary intervention after ST-segment elevation myocardial infarctionKeir McCutcheon, Andreas S Triantafyllis, Thomas Marynissen, et al.
Pacing and Clinical Electrophysiology : PACE|May 21, 2016
Changes in Implantation Patterns and Therapy Rates of Implantable Cardioverter Defibrillators over Time in Ischemic and Dilated Cardiomyopathy PatientsBert Vandenberk, Christophe Garweg, Gabor Voros, et al.
European Journal of Gastroenterology & Hepatology|May 24, 2012
Transcatheter arterial embolization for iatrogenic hemobilia is a safe and effective procedure: case series and review of the literatureThomas Marynissen, Geert Maleux, Sam Heye, et al.
Pageof 1